0001104659-23-083505.txt : 20230724 0001104659-23-083505.hdr.sgml : 20230724 20230724171327 ACCESSION NUMBER: 0001104659-23-083505 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230720 FILED AS OF DATE: 20230724 DATE AS OF CHANGE: 20230724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hochman David P CENTRAL INDEX KEY: 0001292834 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39421 FILM NUMBER: 231105820 MAIL ADDRESS: STREET 1: 15 WESTON HILL RD. CITY: RIVERSIDE STATE: CT ZIP: 06878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc. CENTRAL INDEX KEY: 0001814114 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 BUSINESS PHONE: 646-343-9298 MAIL ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2 DATE OF NAME CHANGE: 20200603 4 1 tm2321855-10_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-07-20 0 0001814114 Orchestra BioMed Holdings, Inc. OBIO 0001292834 Hochman David P C/O ORCHESTRA BIOMED HOLDINGS, INC. 150 UNION SQUARE DRIVE NEW HOPE PA 18938 1 1 0 0 See Remarks 0 Common Stock, par value $0.0001 per share ("Common Stock") 2023-07-20 4 A 0 300000 0 A 465498 D Common Stock 2023-07-20 4 A 0 165000 0 A 227502 I By the DPH 2008 Trust Stock Option (Right to Buy) 7.42 2023-07-20 4 A 0 100500 0 A 2033-07-20 Common Stock 100500 100500 D Stock Option (Right to Buy) 7.42 2023-07-20 4 A 0 132000 0 A 2033-07-20 Common Stock 132000 132000 I By the DPH 2008 Trust Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of January 26, 2023 (the "Vesting Commencement Date"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates. The stock options vest over a four-year period as follows: (i) 25% of the underlying shares will vest on the one-year anniversary of the Vesting Commencement Date and (ii) 75% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting on the last day of the first quarter after the first anniversary of the Vesting Commencement Date, or March 31, 2024, subject to the Reporting Person's continuous service through such dates. Chief Executive Officer and Chairperson /s/ Matthew R. Schob, Attorney-in-Fact 2023-07-24